Phytochemical APIs are active chemical substances with therapeutic qualities that are derived from plants using semi-synthetic techniques. The primary and secondary elements of phytochemicals are split into two categories. Chlorophyll, proteins, sugar, and amino acids are primary phytochemicals, while terpenoids and alkaloids are secondary components. APIs derived from phytochemicals are used by pharmaceutical companies to develop novel medications to treat a variety of ailments.
Download Free PDF Sample: https://www.coherentmarketinsights.com/insight/request-sample/2492
Global Phytochemical API Market Drivers
The phytochemical API market is predicted to develop in response to rising demand for herbal remedies over allopathic pharmaceuticals. Furthermore, increased pharmacognosy research endeavours to develop medications incorporating natural chemical components is another driver driving the phytochemical API market. For example, in 2017, as per new research paper published in the Journal of Natural Compounds, International Cooperative Biodiversity Group discovered new chemical, Patentiflorin A, which is derived from willow-leaved Justicia. Patentiflorin A could inhibit the action of reverse transcriptase much more effectively than Azidothymidine (AZT). AZT is an antiretroviral medicine used to avoid and treat HIV/AIDS. Patentiflorin A acts as a novel anti-HIV agent that can be used with current anti-HIV drugs to suppress the activity of HIV virus and prevent AIDS.
The availability of well-known allopathic pharmaceuticals that cure medical conditions in a shorter time than herbal pharmaceuticals is projected to stymie the expansion of the phytochemical API industry.
Global Phytochemical API Market – Regional Analysis
On the basis of region, the global phytochemical API market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Because of the growing number of pipeline studies to create pharmaceuticals using active chemical compounds taken from plants, the phytochemical API market in North America is predicted to grow favourably. For example, in August 2018, University of Michigan initiated phase 2/phase 3 clinical trial for colchicine, to study the effect of postoperative treatment of colchicine in Fontan patients. Colchicine, an anti-inflammatory agent, is a toxic alkaloid and secondary metabolite extracted from plants of the genus Colchicum. The study is estimated to complete by June 2020.
Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2492
Furthermore, prominent players in Europe are focusing on business tactics such as acquisitions and collaborations to develop their businesses, with the phytochemical API market in the region predicted to grow at a high rate. For example, in 2014, Centroflora CMS, a Luxembourg-based pharmaceutical company, purchased Boehringer Ingelheim’s phytochemical API product line. Boehringer Ingelheim announced a multi-year exclusive arrangement with the company to deliver phytochemical APIs to the market. Chemicals including atropine and atropine sulphate, digoxin, and digoxin micron, as well as metildigoxin, homatropine methylbromide, homatropine hydrobromide, and dihydroergotamine mesylate, are among the products acquired.
Key players for phytochemical API market include Kothari Phytochemicals & Industries Ltd., Lipo Foods, Medipure Pharmaceuticals Inc., Centroflora CMS, SeQuent Scientific Limited, Arboris LLC, Cargill Inc., Indo Phytochem Pharmaceuticals., and BASF SE.
Global Phytochemical API Market Taxonomy
By Molecule Type
- Phenolic acids
- Lignans and stilbenes
By End User
- Herbal based industries
- North America
- Asia Pacific
- Latin America
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027